siRNA treatment lowers triglycerides in individuals along with uncommon disorder

.ANALYSIS FEATURE.19 September 2024.

Plozasiran decreased triglyceride levels by 80% as well as lowered the risk of pancreatitis in clients along with consistent chylomicronemia, with or without a genetic medical diagnosis.